H. Heimpel

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]

Rüdiger Hehlmann, H. Heimpel, Joerg Hasford et al. · Blood · 1994 · 458 citations · Full text

Medicine, Hematology, Oncology +10

Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia

Norbert Frickhofen, H. Heimpel, J. P. Kaltwasser et al. · Blood · 2003 · 330 citations · Full text

Medicine, Hematology, Pharmacology +8

Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin

JW Janssen, Michael Buschle, Mark Layton et al. · Blood · 1989 · 307 citations · Full text

Life Sciences, Cell Biology, Hematology +13

Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults

D. Hoelzer, E. Thiel, H. Löffler et al. · Blood · 1984 · 300 citations · Full text

Medicine, Hematology, Oncology +13

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV

Rüdiger Hehlmann, Martin C. Müller, Michael Lauseker et al. · Journal of Clinical Oncology · 2013 · 299 citations · Full text

Medicine, Hematology, Pharmacology +13